Providing Investor Relations, Public Relations, Corporate Communications and Capital Markets Advisory Services to Greater Boston and Cambridge Life Sciences Companies
NEW YORK, Oct. 12, 2017 -- LifeSci Advisors, an investor relations and corporate communications firm focused on the life sciences sector (“LifeSci”), today announces the opening of an office in Boston, enhancing its presence in the Greater Boston and Cambridge communities. The office will be managed by Hans Vitzthum, managing director with LifeSci Advisors.
“Massachusetts has long been a hub for groundbreaking biotech research and drug development in the life sciences industry, so it was a natural decision to expand our local presence to the Boston area,” said Michael Rice, President and co-founder of LifeSci Advisors. “Our Boston-based team has long-standing relationships within the local investment and life sciences communities and looks forward to more efficiently delivering our extensive service offering to the Greater Boston and Cambridge biotech and pharma communities.”
In addition to its Boston location, LifeSci has a physical presence in New York, where the firm is headquartered, Chicago, Philadelphia, London, Geneva and Tel Aviv. The firm’s capabilities include global corporate access through non-deal roadshows and targeted investor and KOL events, corporate communications, and corporate governance consulting. Through its affiliates, LifeSci also provides its clients capital markets solutions, equity research coverage, and public relations services.
Vitzthum has more than 25 years’ experience in institutional sales and healthcare research product management at Leerink Partners, Cowen & Co., and Lazard Capital Markets. He spent 12 years running the morning research call at two investment banks and has served as the “Deal Captain” on more than 100 healthcare IPOs and secondary offerings. Vitzthum has worked in healthcare research product management for the past 15 years and has developed extensive and long-standing relationships within the institutional investment community. He has an Applied Baccalaureate from Columbia College.
LifeSci Advisors, LLC (www.lifesciadvisors.com) is the largest investor relations consultancy in the life sciences industry, founded to provide companies with a multi-faceted approach to investor communications and outreach. With a global focus and reach, the firm provides the highest quality service for its clients through its deep sector specialization. LifeSci’s team of MDs and PhDs enables the firm to better understand clients' R&D, regulatory and commercial strategies, and its team of financial services, investor relations and public relations specialists helps clients effectively communicate to the marketplace. This combination of life sciences, financial services, and investor relations competencies allows LifeSci Advisors to provide an invaluable and unique service offering to clients.
LifeSci Partners (www.lifescipartners.com) is the leading provider of consulting services in the areas of investor relations, public relations, corporate communications and capital markets advisory. Combining deep domain expertise in the life sciences with decades of experience in capital markets and public relations, LifeSci Partners delivers unparalleled services to life sciences companies globally.
For further information, please contact:
Michael Rice
LifeSci Advisors
646-597-6979
[email protected]


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Instagram Outage Disrupts Thousands of U.S. Users
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



